101. Platelet activity and outcome after intracerebral hemorrhage.
- Author
-
Naidech AM, Bernstein RA, Levasseur K, Bassin SL, Bendok BR, Batjer HH, Bleck TP, and Alberts MJ
- Subjects
- Aged, Aged, 80 and over, Blood Platelets physiology, Cerebral Hemorrhage blood, Cerebral Hemorrhage physiopathology, Clopidogrel, Female, Glasgow Coma Scale, Humans, Male, Middle Aged, Platelet Activation drug effects, Platelet Function Tests, Prospective Studies, Severity of Illness Index, Ticlopidine therapeutic use, Treatment Outcome, Aspirin therapeutic use, Blood Platelets drug effects, Cerebral Hemorrhage drug therapy, Platelet Aggregation Inhibitors therapeutic use, Ticlopidine analogs & derivatives
- Abstract
There are few data on platelet function in intracerebral hemorrhage (ICH). We prospectively enrolled 69 patients with ICH and measured platelet function on admission. Aspirin use before ICH was associated with reduced platelet activity. Less platelet activity was associated with intraventricular hemorrhage (516.5 [interquartile range (IQR), 454-629.25] vs 637 [IQR, 493-654] aspirin reaction units; p = 0.04) and death at 14 days (480.5 [IQR, 444.5-632.5] vs 626 [IQR, 494-652] aspirin reaction units; p = 0.04). Objective measures of platelet function on admission are associated with intraventricular hemorrhage and death after ICH.
- Published
- 2009
- Full Text
- View/download PDF